Display options
Share it on

Calcif Tissue Int. 1991;49:S55-9. doi: 10.1007/BF02555090.

Role of oestrogen in the development of osteoporosis.

Calcified tissue international

T C Hillard, J C Stevenson

Affiliations

  1. Wynn Institute for Metabolic Research, London, England.

PMID: 1933600 DOI: 10.1007/BF02555090

Abstract

The evidence now strongly supports a central role for oestrogen in the maintenance of the normal female skeleton. Loss of endogenous oestrogen leads to a period of accelerated bone loss which can be prevented with appropriate oestrogen replacement. The route of administration is not important provided adequate dosages are prescribed. Oestrogens may exert their actions by a direct steroid receptor mechanism or via local and/or systemic factors such as cytokines, prostaglandins or calcitonin. As the requirement for osteoporosis prevention grows, it is essential that the extent of the involvement oestrogen has in skeletal homeostasis is fully recognized.

References

  1. J Biomech. 1985;18(3):189-200 - PubMed
  2. Science. 1988 Jul 1;241(4861):81-4 - PubMed
  3. Endocrinology. 1987 Aug;121(2):819-21 - PubMed
  4. Clin Endocrinol (Oxf). 1989 Apr;30(4):435-42 - PubMed
  5. J Lab Clin Med. 1978 Dec;92(6):964-70 - PubMed
  6. Lancet. 1981 Mar 28;1(8222):693-5 - PubMed
  7. J Clin Invest. 1969 Jun;48(6):1065-72 - PubMed
  8. Lancet. 1982 Feb 27;1(8270):475-8 - PubMed
  9. Am J Obstet Gynecol. 1987 Jun;156(6):1516-23 - PubMed
  10. Eur J Clin Invest. 1980 Aug;10(4):273-9 - PubMed
  11. Bone Miner. 1989 Apr;6(1):55-63 - PubMed
  12. Acta Orthop Scand. 1985 Feb;56(1):25-7 - PubMed
  13. Lancet. 1981 Aug 8;2(8241):277-9 - PubMed
  14. Lancet. 1978 May 6;1(8071):961-2 - PubMed
  15. J Clin Invest. 1982 Oct;70(4):716-23 - PubMed
  16. Eur J Clin Invest. 1983 Dec;13(6):481-7 - PubMed
  17. Baillieres Clin Endocrinol Metab. 1988 Feb;2(1):87-101 - PubMed
  18. Lancet. 1988 Apr 23;1(8591):900-2 - PubMed
  19. Br Med J (Clin Res Ed). 1988 Apr 23;296(6630):1150-2 - PubMed
  20. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4616-20 - PubMed
  21. J Bone Miner Res. 1986 Aug;1(4):339-49 - PubMed
  22. J Bone Miner Res. 1989 Aug;4(4):625-31 - PubMed
  23. Lancet. 1976 May 15;1(7968):1038-41 - PubMed
  24. Bone. 1986;7(2):119-23 - PubMed
  25. Proc Soc Exp Biol Med. 1974 May;146(1):265-8 - PubMed
  26. Br Med J (Clin Res Ed). 1984 Sep 1;289(6444):517-20 - PubMed
  27. Science. 1988 Jul 1;241(4861):84-6 - PubMed
  28. N Engl J Med. 1985 Apr 25;312(17):1097-100 - PubMed
  29. Lancet. 1987 Dec 26;2(8574):1481-3 - PubMed
  30. Clin Sci (Lond). 1982 Mar;62(3):329-36 - PubMed
  31. J Immunol. 1986 Apr 1;136(7):2478-82 - PubMed
  32. Am J Obstet Gynecol. 1987 Jan;156(1):61-5 - PubMed
  33. J Bone Miner Res. 1987 Dec;2(6):491-6 - PubMed
  34. Lancet. 1990 Aug 4;336(8710):265-9 - PubMed
  35. J Clin Invest. 1989 Mar;83(3):1073-7 - PubMed
  36. Endocrinology. 1978 Jan;102(1):236-44 - PubMed
  37. Calcif Tissue Int. 1988 Feb;42(2):77-86 - PubMed
  38. Ann Intern Med. 1987 Jan;106(1):40-5 - PubMed
  39. Obstet Gynecol. 1990 Aug;76(2):290-5 - PubMed
  40. N Engl J Med. 1988 Mar 31;318(13):818-28 - PubMed
  41. N Engl J Med. 1980 Nov 20;303(21):1195-8 - PubMed
  42. BMJ. 1989 Apr 8;298(6678):924-8 - PubMed
  43. Bone Miner. 1987 Apr;2(2):141-6 - PubMed
  44. Calcif Tissue Int. 1988 Feb;42(2):71-6 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources